Pricing Log in Create free account
Friday 6 November 2026 Export ELAN’s income statement to Excel — free account

Elanco Animal Health Incorporated

ELAN Healthcare Drug Manufacturers Specialty & Generic

Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.

Revenue
+10.2%
EPS
+450.0%
Free cash flow
+35.6%
Total debt
−6.91%

Quarter to June 2026, against a year earlier

23.74 1.57 −6.20%
Market cap
$11.8B
P/E
0.0×
Fwd P/E
161×
Dividend yield
—
F-score
5/9
Altman Z
1.28
Beneish M
−2.68
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Elanco Animal Health Incorporated (ELAN) Book value per share

Alert me on Book value per share

Elanco Animal Health Incorporated's book value per share at the end of fiscal 2025 was 13.2×, up 6.88% from 12.3× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 13.2×. Over the past ten years it has ranged from 0.0× (fiscal 2015) to 26.5× (fiscal 2017); the current reading is higher than 36% of that period. Elanco Animal Health Incorporated ranks 12th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 13.2× 6.88%
FY2024 12.3× (2.38%)
FY2023 12.6× (15.32%)
FY2022 14.9× (3.14%)
FY2021 15.4× (19.75%)
FY2020 19.2× 27.74%
FY2019 15.0× (9.27%)
FY2018 16.6× (37.54%)
FY2017 26.5× 10.71%
FY2016 24.0× —

Quarterly newest first

Period Book value per share Change
Jun 2026 13.2× 0.99%
Mar 2026 13.1× (0.98%)
Dec 2025 13.2× (2.91%)
Sep 2025 13.6× (0.42%)
33 more quarters

Against its own ten years

Low 0.0× High 26.5×
Ten-year median 15.0×
Current reading's percentile 36

Book value per share against peers

Company Book value per share
NBIX Neurocrine Biosciences, Inc. compare 38.2×
LNTH Lantheus Holdings, Inc. compare 20.8×
ELAN Elanco Animal Health Incorporated 13.2×
ALKS Alkermes plc compare 11.1×
KNSA Kiniksa Pharmaceuticals International, plc compare 9.1×
RDY Dr. Reddy's Laboratories Ltd compare 4.9×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 1.6×
HIMS Hims & Hers Health, Inc. compare 1.4×
VTRS Viatris Inc. compare 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on ELAN